RxDoctor Payments Data

Jacob Koruth, MD

Clinical Cardiac Electrophysiology · New York, NYNPI 1265652051

Payments from drug & device makers

What this record shows

This record is dominated by other: $2,696,537 of the $3,654,414 with a category attached, or 73.8%. Medtronic accounts for 70.7% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $1,942,788 and has fallen 76.3% since, to $460,179 in 2025. Among clinical cardiac electrophysiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,654,414in general payments, 2019–2025

Across 732 payments — averaging $4992.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2.6M
  • Boston Scientific$448K
  • Abbott$231K
  • Pulse Biosciences, Inc.$207K
  • Biosense Webster, Inc.$82K
  • Acutus Medical, Inc.$47K
  • plus $57K from 12 others
$299,527in research payments, 2019–2025

Across 14 payments — averaging $21,395 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cardiofocus, Inc.$252K
  • Medtronic$48K

What the payments were for

  • Consulting fees$556,99115%
  • Speaking & faculty fees$247,6287%
  • Grants$6,3720%
  • Travel & lodging$129,0304%
  • Food & beverage$17,8560%
  • Other$2,696,53774%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,654,414 in reported general payments places this provider in the 95th percentile of 214 clinical cardiac electrophysiology providers in New York.

See all clinical cardiac electrophysiology providers in New York

Medicare billing

Part B allowed, 2024
$260,336
Medicare patients
2,011
Services billed
4,213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban44$44,808
Dofetilide38$7,504
Flecainide Acetate26$381
Metoprolol Succinate33$314
Amiodarone Hcl11$59

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →